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Background
The treatment of cancer is undergoing a revolution,
thanks to new advances in the understanding of the
immune system. As part of an ongoing educational cur-
riculum, initial assessment of oncologists’ knowledge
and practice patterns in the use of immunotherapies
identified several challenges. This study’s objective was
to assess and compare practicing oncologists’ comfort
level with, and comprehension of, immune-oncologic
concepts that play an important role in the care of
patients with metastatic cancer.
Methods
An expert panel was convened to identify knowledge,
competence and performance gaps in the area of
immuno-oncology (IO). Educational curricula consisting
of 6 activities focused on foundational education were
developed in 2014 and 2015, and posted online. Intra-
activity questions embedded in each program allowed
learners to self-report their familiarity with IO concepts,
while participants’ responses to knowledge- -based ques-
tions presented before and after education were col-
lected to measure gains in knowledge. Confidentiality of
respondents was maintained. Responses were collected
from 5/2014-6/2015.
Results
Oncologists (N=4,126) who participated in one of the
six foundational activities demonstrated on average a
20% improvement from initial baseline in year 1. Year-
over-year comparison of oncologists’ knowledge of the
role of immune checkpoints in the adaptive immune
response indicates that a majority of gains observed in
year 1, were maintained into the second year of the cur-
riculum. Moreover, additional educational exposure in
year 2 of the curriculum allowed recapturing and further
augmenting of gains in oncologists’ understanding of
immune checkpoint regulation.
However, despite the success of the curriculum, oncol-
ogists continued to report a lack of familiarity and com-
fort with IO . Only 11% were very comfortable with
prescribing immunotherapies for their cancer patients
with advanced disease while 60% characterized them-
selves as not knowledgeable about CAR T cell therapy.
Additional continued clinical challenges that emerged
from assessments embedded in specific activities include:
• 25% incorrectly identified CTLA-4, an immune
checkpoint, as an activating T cell receptor
• 36-56% failed to understand the role of tumor
microenviroment in regulating the adaptive immune
response
• 67% did not recognize the mechanism of action
and associated long-term activation of CAR T cell
therapy
• 59% did not comprehend how to appropriately
manage IO treatment-related side effects prior to
completing the activity
Conclusions
This study demonstrates the value of and continued need
for appropriately designed online educational interventions
on basic concepts of IO. Improvements in competence
among oncologists should have beneficial implications for
practice and ultimately for patient outcomes.
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